<img src="https://publish-01.obsidian.md/access/744ac39d33cabbc297b91373bfcac24d/bin/images/Thailand_map.png" alt="Thailand" class="page-header-sidebar-image"> Thailand has provisions in its legislation relating to the granting of compulsory licences. These can be found in the Patent Act B.E. 2522 (1979). There are four main grounds for issuing a compulsory licence: - Non-working / inadequate “working” Patent not locally produced or imported, or sold at unreasonably high price relative to domestic demand. - Dependent patents Use of a later patent requiring the earlier patent’s invention. - Public non-commercial/government use For public health, environmental conservation, food/medicine shortages, etc. - National emergency / public interest Covers war, epidemics (e.g., HIV/AIDS, SARS, bird flu), national emergencies. More information can be found [here](https://www.wipo.int/wipolex/en/legislation/details/3807 ). ## Compulsory licences Thailand has granted compulsory licence for: - [[Erlotinib]] - [[EFV-FTC-TDF, 3TC-AZT-EFV]] - [[Letrozole]] - [[ARVs]] - [[EFV-FTC-TDF, 3TC-AZT-EFV]] - [[AZT, 3TC, D4T, NVP, 3TC-AZT]] - [[Docetaxel]] - [[Clopidogrel]] - [[LPV-r]] Thailand has been requested to issue a compulsory licence for [[Imatinib]] by the government. The compulsory licence has not been issued because donations were made instead.